E-LIB Suche - Ergebnisse für: Müller, Martin C.

1

POSTER: CML-310 Early Cytogenetic or Molecular Landmark Res..:

Müller, Martin C. ; Cortes, Jorge ; Chuah, Charles...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S175 , 2023

Link: https://doi.org/10.1016/..

2

CML-310 Early Cytogenetic or Molecular Landmark Response to..:

Müller, Martin C. ; Cortes, Jorge ; Chuah, Charles...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S336-S337 , 2023

Link: https://doi.org/10.1016/..

3

P670: EARLY CYTOGENETIC OR MOLECULAR LANDMARK RESPONSE TO P..:

Müller, Martin C. ; Cortes, Jorge ; Chuah, Charles...
HemaSphere. 7 (2023) S3 - p. e88427a9 , 2023

Link: https://doi.org/10.1097/..

4

Defining therapy goals for major molecular remission in chr..:

Saussele, Susanne ; Hehlmann, Rüdiger ; Fabarius, Alice...
Leukemia. 32 (2018) 5 - p. 1222-1228 , 2018

Link: https://doi.org/10.1038/..

5

Ponatinib in chronic myeloid leukemia (CML): Consensus on p..:

Müller, Martin C. ; Cervantes, Francisco ; Hjorth-Hansen, Henrik...
Critical Reviews in Oncology/Hematology. 120 (2017) - p. 52-59 , 2017

Link: https://doi.org/10.1016/..

6

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment S..:

Padula, William V. ; Larson, Richard A. ; Dusetzina, Stacie B....
Journal of the National Cancer Institute. 108 (2016) 7 - p. djw003 , 2016

Link: https://doi.org/10.1093/..

7

c-MYB is a transcriptional regulator of ESPL1/Separase in B..:

Prinzhorn, Wiltrud ; Stehle, Michael ; Kleiner, Helga...
Biomarker Research. 4 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

8

Clonal Evolution and Blast Crisis Correlate with Enhanced P..:

Haaß, Wiltrud ; Kleiner, Helga ; Weiß, Christel...
PLOS ONE. 10 (2015) 6 - p. e0129648 , 2015

Link: https://doi.org/10.1371/..

9

Molecular monitoring of chronic myeloid leukemia: principle..:

Cross, Nicholas C. P. ; Hochhaus, Andreas ; Müller, Martin C.
Annals of Hematology. 94 (2015) S2 - p. 219-225 , 2015

Link: https://doi.org/10.1007/..

10

Measurement of Separase Proteolytic Activity in Single Livi..:

Haaß, Wiltrud ; Kleiner, Helga ; Müller, Martin C....
PLOS ONE. 10 (2015) 8 - p. e0133769 , 2015

Link: https://doi.org/10.1371/..

11

Response-related predictors of survival in CML:

Hanfstein, Benjamin ; Müller, Martin C. ; Hochhaus, Andreas
Annals of Hematology. 94 (2015) S2 - p. 227-239 , 2015

Link: https://doi.org/10.1007/..

12

Ponatinib in Heavily Pretreated Leukemia: 3-Year PACE Trial..:

Cortes, Jorge E. ; Kim, Dong-Wook ; Pinilla-Ibarz, Javier...
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. S35-S36 , 2015

Link: https://doi.org/10.1016/..

13

Nilotinib in patients with systemic mastocytosis: analysis ..:

Hochhaus, Andreas ; Baccarani, Michele ; Giles, Francis J....
Journal of Cancer Research and Clinical Oncology. 141 (2015) 11 - p. 2047-2060 , 2015

Link: https://doi.org/10.1007/..

14

Impact of unbalanced minor route versus major route karyoty..:

for the SAKK and the German CML Study Group ; Fabarius, Alice ; Kalmanti, Lida...
Annals of Hematology. 94 (2015) 12 - p. 2015-2024 , 2015

Link: https://doi.org/10.1007/..

15

Implications of BCR-ABL1 kinase domain-mediated resistance ..:

Soverini, Simona ; Branford, Susan ; Nicolini, Franck E....
Leukemia Research. 38 (2014) 1 - p. 10-20 , 2014

Link: https://doi.org/10.1016/..